Karyotype

Karyotype refers to the complete set of chromosomes within a cell, including their number, size, and structural features, typically visualised through microscopic analysis during metaphase when chromosomes are condensed and distinguishable. This chromosomal profile provides a fundamental genetic overview, enabling identification of numerical abnormalities such as aneuploidy and structural alterations including translocations, deletions, duplications, and inversions. Karyotyping is widely used in genetics, oncology, reproductive medicine, and cell line characterisation.

The biopharmaceutical industry applies karyotype analysis in multiple areas including cell line development, genetic stability monitoring, and clinical diagnostics. Manufacturing cell lines used for biologic production undergo karyotype evaluation to ensure stability across passages and minimise risks of drift impacting productivity or product quality. In oncology, karyotyping supports diagnosis and classification of malignancies such as leukaemias and lymphomas where characteristic chromosomal rearrangements guide prognosis and treatment selection. Cytogenetic findings also inform clinical trial stratification and biomarker strategies in precision medicine. Regulatory expectations require demonstrating cell substrate characterisation and stability, making karyotype analysis a valuable tool for supporting product quality and compliance.